Handelsbanken Fonder’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-24,202
Closed -$347K 1521
2025
Q3
$347K Hold
24,202
﹤0.01% 1392
2025
Q2
$297K Sell
24,202
-4,700
-16% -$68.2K ﹤0.01% 1429
2025
Q1
$636K Buy
28,902
+5,300
+22% +$125K ﹤0.01% 1145
2024
Q4
$535K Hold
23,602
﹤0.01% 1257
2024
Q3
$429K Buy
23,602
+4,400
+23% +$102K ﹤0.01% 1310
2024
Q2
$560K Buy
19,202
+6,900
+56% +$205K ﹤0.01% 1109
2024
Q1
$436K Hold
12,302
﹤0.01% 1229
2023
Q4
$536K Buy
12,302
+3,000
+32% +$118K ﹤0.01% 1112
2023
Q3
$355K Hold
9,302
﹤0.01% 1229
2023
Q2
$383K Hold
9,302
﹤0.01% 1215
2023
Q1
$534K Sell
9,302
-2,400
-21% -$135K ﹤0.01% 981
2022
Q4
$656K Hold
11,702
﹤0.01% 817
2022
Q3
$496K Hold
11,702
﹤0.01% 968
2022
Q2
$632K Hold
11,702
﹤0.01% 889
2022
Q1
$752K Sell
11,702
-2,300
-16% -$151K ﹤0.01% 930
2021
Q4
$938K Hold
14,002
﹤0.01% 933
2021
Q3
$959K Hold
14,002
0.01% 930
2021
Q2
$955K Buy
14,002
+800
+6% +$56.6K 0.01% 949
2021
Q1
$912K Hold
13,202
0.01% 883
2020
Q4
$857K Hold
13,202
0.01% 893
2020
Q3
$623K Hold
13,202
﹤0.01% 897
2020
Q2
$620K Buy
+13,202
New +$649K 0.01% 862

Other funds holding IART

Handelsbanken Fonder's IART Position: Q4 2025 in Review

Handelsbanken Fonder sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 24,202 shares — an estimated $347K sold.

Handelsbanken Fonder first reported a position in IART in Q2 2020 and held it in 22 quarters. The position peaked at $959K in Q3 2021. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

  • Handelsbanken Fonder reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
  • Handelsbanken Fonder sold 24,202 Integra LifeSciences shares in Q4 2025, an estimated $347K.
  • Handelsbanken Fonder first reported a position in Integra LifeSciences in Q2 2020 and held it in 22 quarters.
  • Handelsbanken Fonder's Integra LifeSciences position peaked at $959K in Q3 2021.
  • 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.